Fiona Dove

886 total citations
8 papers, 534 citations indexed

About

Fiona Dove is a scholar working on Cardiology and Cardiovascular Medicine, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Fiona Dove has authored 8 papers receiving a total of 534 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Cardiology and Cardiovascular Medicine, 3 papers in Pathology and Forensic Medicine and 2 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Fiona Dove's work include Cardiovascular Health and Disease Prevention (5 papers), Vitamin D Research Studies (3 papers) and Bone health and osteoporosis research (2 papers). Fiona Dove is often cited by papers focused on Cardiovascular Health and Disease Prevention (5 papers), Vitamin D Research Studies (3 papers) and Bone health and osteoporosis research (2 papers). Fiona Dove collaborates with scholars based in United Kingdom, Sweden and Italy. Fiona Dove's co-authors include Miles D. Witham, Allan D. Struthers, Jacqui Sugden, Moira Dryburgh, Andrew D. Morris, Faisel Khan, Alex S. F. Doney, J. J. F. Belch, Chim C. Lang and Helen C. Looker and has published in prestigious journals such as Diabetologia, Diabetes Obesity and Metabolism and International Journal of Cardiology.

In The Last Decade

Fiona Dove

8 papers receiving 514 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fiona Dove United Kingdom 8 332 203 137 134 78 8 534
Nino Kavtaradze United States 11 246 0.7× 113 0.6× 133 1.0× 280 2.1× 60 0.8× 22 759
Irina Uphoff United States 7 229 0.7× 89 0.4× 67 0.5× 215 1.6× 54 0.7× 13 463
Frank Holden Mose Denmark 11 188 0.6× 107 0.5× 69 0.5× 104 0.8× 54 0.7× 40 462
Yuen-Fung Yiu China 4 203 0.6× 105 0.5× 58 0.4× 115 0.9× 41 0.5× 5 326
S. Bandinelli Italy 13 147 0.4× 97 0.5× 114 0.8× 231 1.7× 77 1.0× 18 751
F. Saleh Norway 7 246 0.7× 88 0.4× 37 0.3× 55 0.4× 80 1.0× 8 442
A-M. Borissova Bulgaria 5 299 0.9× 145 0.7× 146 1.1× 17 0.1× 54 0.7× 7 437
Lavienja A. J. L. M. Braam Netherlands 13 159 0.5× 669 3.3× 110 0.8× 55 0.4× 96 1.2× 13 1.0k
S Krutzik United States 10 119 0.4× 214 1.1× 120 0.9× 77 0.6× 99 1.3× 18 781
Myrtle Thierry-Palmer United States 11 165 0.5× 97 0.5× 72 0.5× 76 0.6× 15 0.2× 32 353

Countries citing papers authored by Fiona Dove

Since Specialization
Citations

This map shows the geographic impact of Fiona Dove's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fiona Dove with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fiona Dove more than expected).

Fields of papers citing papers by Fiona Dove

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fiona Dove. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fiona Dove. The network helps show where Fiona Dove may publish in the future.

Co-authorship network of co-authors of Fiona Dove

This figure shows the co-authorship network connecting the top 25 collaborators of Fiona Dove. A scholar is included among the top collaborators of Fiona Dove based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fiona Dove. Fiona Dove is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Khan, Faisel, Isabel Gonçalves, Angela C. Shore, et al.. (2022). Plaque characteristics and biomarkers predicting regression and progression of carotid atherosclerosis. Cell Reports Medicine. 3(7). 100676–100676. 12 indexed citations
2.
Mordi, Ify, J. Graeme Houston, Helen M. Colhoun, et al.. (2018). Epicardial adipose tissue is related to arterial stiffness and inflammation in patients with cardiovascular disease and type 2 diabetes. BMC Cardiovascular Disorders. 18(1). 31–31. 36 indexed citations
3.
Natali, Andrea, Lorenzo Nesti, Elena Venturi, et al.. (2018). Metformin is the key factor in elevated plasma growth differentiation factor‐15 levels in type 2 diabetes: A nested, case–control study. Diabetes Obesity and Metabolism. 21(2). 412–416. 37 indexed citations
4.
Casanova, Francesco, Damilola D. Adingupu, F. Dennette Adams, et al.. (2017). The impact of cardiovascular co-morbidities and duration of diabetes on the association between microvascular function and glycaemic control. Cardiovascular Diabetology. 16(1). 114–114. 54 indexed citations
5.
Weir‐McCall, Jonathan, Faisel Khan, Deirdre Cassidy, et al.. (2017). Effects of inaccuracies in arterial path length measurement on differences in MRI and tonometry measured pulse wave velocity. BMC Cardiovascular Disorders. 17(1). 118–118. 17 indexed citations
6.
Witham, Miles D., Fiona Dove, Faisel Khan, et al.. (2012). Effects of Vitamin D supplementation on markers of vascular function after myocardial infarction—A randomised controlled trial. International Journal of Cardiology. 167(3). 745–749. 64 indexed citations
7.
Witham, Miles D., Fiona Dove, Moira Dryburgh, et al.. (2010). The effect of different doses of vitamin D3 on markers of vascular health in patients with type 2 diabetes: a randomised controlled trial. Diabetologia. 53(10). 2112–2119. 216 indexed citations
8.
Witham, Miles D., Fiona Dove, Jacqui Sugden, Alex S. F. Doney, & Allan D. Struthers. (2010). The effect of vitamin D replacement on markers of vascular health in stroke patients – A randomised controlled trial. Nutrition Metabolism and Cardiovascular Diseases. 22(10). 864–870. 98 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026